- Home
- FONR vs ADAG Comparison
FONR vs ADAG Comparison
Compare FONR & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FONR
- ADAG
- Stock Information
- Founded
- FONR 1978
- ADAG 2011
- Country
- FONR United States
- ADAG China
- Employees
- FONR N/A
- ADAG N/A
- Industry
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- FONR Health Care
- ADAG Health Care
- Exchange
- FONR Nasdaq
- ADAG Nasdaq
- Market Cap
- FONR 100.6M
- ADAG 84.4M
- IPO Year
- FONR 1987
- ADAG 2021
- Fundamental
- Price
- FONR $14.70
- ADAG $1.60
- Analyst Decision
- FONR
- ADAG Strong Buy
- Analyst Count
- FONR 0
- ADAG 3
- Target Price
- FONR N/A
- ADAG $7.67
- AVG Volume (30 Days)
- FONR 14.8K
- ADAG 55.1K
- Earning Date
- FONR 09-26-2025
- ADAG 08-12-2025
- Dividend Yield
- FONR N/A
- ADAG N/A
- EPS Growth
- FONR N/A
- ADAG N/A
- EPS
- FONR 1.26
- ADAG N/A
- Revenue
- FONR $104,351,318.00
- ADAG $103,204.00
- Revenue This Year
- FONR N/A
- ADAG $7,411.34
- Revenue Next Year
- FONR N/A
- ADAG $28.29
- P/E Ratio
- FONR $11.66
- ADAG N/A
- Revenue Growth
- FONR 1.43
- ADAG N/A
- 52 Week Low
- FONR $12.00
- ADAG $1.30
- 52 Week High
- FONR $17.62
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- FONR 32.90
- ADAG 39.96
- Support Level
- FONR $14.71
- ADAG $1.47
- Resistance Level
- FONR $14.97
- ADAG $1.74
- Average True Range (ATR)
- FONR 0.24
- ADAG 0.14
- MACD
- FONR -0.08
- ADAG -0.02
- Stochastic Oscillator
- FONR 0.00
- ADAG 33.33
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.